vs
Side-by-side financial comparison of Integer Holdings Corp (ITGR) and LivaNova PLC (LIVN). Click either name above to swap in a different company.
Integer Holdings Corp is a global medical device contract manufacturing partner for leading healthcare and medtech enterprises. It designs, develops and produces high-precision components, assemblies and finished medical devices across core segments including cardiac care, neuromodulation, orthopedics and portable medical products, serving markets across North America, Europe and Asia-Pacific.
LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $360.9M | ||
| Q3 25 | — | $357.8M | ||
| Q2 25 | — | $352.5M | ||
| Q1 25 | — | $316.9M | ||
| Q4 24 | — | $321.8M | ||
| Q3 24 | — | $318.1M | ||
| Q2 24 | — | $318.6M | ||
| Q1 24 | — | $294.9M |
| Q4 25 | — | $30.9M | ||
| Q3 25 | — | $26.8M | ||
| Q2 25 | — | $27.2M | ||
| Q1 25 | — | $-327.3M | ||
| Q4 24 | — | $55.9M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $16.3M | ||
| Q1 24 | — | $-41.9M |
| Q4 25 | — | 65.2% | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | 67.8% | ||
| Q1 25 | — | 69.7% | ||
| Q4 24 | — | 68.2% | ||
| Q3 24 | — | 70.8% | ||
| Q2 24 | — | 68.7% | ||
| Q1 24 | — | 70.3% |
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 11.5% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 12.6% | ||
| Q1 24 | — | 5.5% |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 7.5% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | -103.3% | ||
| Q4 24 | — | 17.4% | ||
| Q3 24 | — | 10.4% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | -14.2% |
| Q4 25 | — | $0.57 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $0.50 | ||
| Q1 25 | — | $-6.01 | ||
| Q4 24 | — | $1.04 | ||
| Q3 24 | — | $0.60 | ||
| Q2 24 | — | $0.30 | ||
| Q1 24 | — | $-0.78 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
